Central retinal vein occlusion treated with Ozurdex: a case report and review of literature

F Semeraro, A Russo, P Danzi… - Journal of ocular …, 2013 - liebertpub.com
Journal of ocular pharmacology and therapeutics, 2013liebertpub.com
Purpose: To describe the retinal changes occurring after Ozurdex®(Ozurdex, Allergan, Inc.,
Irvine, CA) injection and peripheral laser treatment in a case of central retinal vein occlusion
(CRVO). Case Report: A 51-year-old Caucasian man with massive retinal edema (926 μm)
and hand motion visual acuity due to severe CRVO was treated early with Ozurdex
intravitreal injection. Detailed monthly follow-up examinations showed complete resorption
of the edema (253 μm) after 2 months and a 20/32 visual outcome after 3 months. The …
Abstract
Purpose: To describe the retinal changes occurring after Ozurdex® (Ozurdex, Allergan, Inc., Irvine, CA) injection and peripheral laser treatment in a case of central retinal vein occlusion (CRVO).
Case Report: A 51-year-old Caucasian man with massive retinal edema (926 μm) and hand motion visual acuity due to severe CRVO was treated early with Ozurdex intravitreal injection. Detailed monthly follow-up examinations showed complete resorption of the edema (253 μm) after 2 months and a 20/32 visual outcome after 3 months. The patient subsequently developed peripheral retinal ischemia accompanied by recurrence of small retinal cystoid spaces (295 μm); therefore, he underwent an associated laser treatment on the involved peripheral retina, which led to a recovery in retinal thickness (280 μm). His visual acuity remained stable at 20/32.
Conclusions: Early Ozurdex injection in association with late laser photocoagulation was effective in the resorption of CRVO macular edema and in restoring reasonably good visual acuity.
Mary Ann Liebert
以上显示的是最相近的搜索结果。 查看全部搜索结果